Novavax (NVAX) develops a vaccine candidate to protect against Middle East Respiratory Syndrome...

|By:, SA News Editor

Novavax (NVAX) develops a vaccine candidate to protect against Middle East Respiratory Syndrome Coronavirus, a newly emergent virus which belongs to the same family as its more famous cousin SARS-CoV. Shares +15% premarket. (PR)